Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Long-Term Data Confirm Early Rituximab Monotherapy Delays New Treatment in Advanced, Asymptomatic LTBFL Free
Katie Robinson
July 31, 2025
Exploring Heterozygote Bleeding Risk in Rare Bleeding Disorders Free
Ruth Jessen Hickman, MD
July 31, 2025
Cytokine-Secreting CAR T-Cell Candidate Therapy Shows Preliminary Efficacy in Patients With Lymphoma Free
Anna Azvolinsky, PhD
July 31, 2025
Study Validates Revised FLC Reference Intervals, Improving Prognostic Accuracy in MGUS Free
Khylia Marshall
July 31, 2025
Iron Deficiency Potentially Underdiagnosed in Females With Bleeding Disorders Free
Ruth Jessen Hickman, MD
July 16, 2025
Critical Limb Ischemia Outcomes Worse Among Those With MPNs Free
Leah Lawrence
June 16, 2025
Real-World Venetoclax Combinations for MM Show Evidence of Efficacy in Patients Harboring t(11;14) Free
Thomas R. Collins
June 16, 2025
Quadruplet Therapy Safe, Effective for Some Frail Patients with NDMM Free
Leah Lawrence
June 10, 2025
Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM Free
Katie Robinson
May 28, 2025
24-Hour Urine-Based Response Test Not Necessary for MM Free
Leah Lawrence
May 28, 2025
Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency Free
Anna Azvolinsky, PhD
May 22, 2025
Analysis Offers Insight Into CAR-T-Related Secondary Malignancies Free
Thomas R. Collins
May 22, 2025
Combination Pelabresib-Ruxolitinib Shows Disease Burden Benefit in Patients With Myelofibrosis Free
Khylia Marshall
May 22, 2025
Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds Free
Thomas R. Collins
May 1, 2025
Fixed-Duration Acalabrutinib Combinations Effective for Untreated CLL Free
Lara C. Pullen, PhD
May 1, 2025
Intensive Factor VIII Prophylaxis May Benefit Patients with Hemophilia, Hypertrophic Synovium Free
Ruth Jessen Hickman, MD
May 1, 2025
Abelacimab Demonstrates Safety, Superior Bleeding Reduction Compared With Rivaroxaban in Atrial Fibrillation Free
Khylia Marshall
April 10, 2025
Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma Free
Katie Robinson
April 10, 2025
BCMA-Targeting CAR-T With Innovative Manufacturing Process Shows Early Activity for R/R MM Free
Leah Lawrence
April 10, 2025
Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist Free
Thomas R. Collins
April 10, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
July 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals